These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1667485)

  • 1. A preliminary study on the immunogenicity in rabbits and in human volunteers of a recombinant vaccinia virus expressing Epstein-Barr virus membrane antigen.
    Gu S; Huang T; Miao Y; Ruan L; Zhao Y; Han C; Xiao Y; Zhu J; Wolf H
    Chin Med Sci J; 1991 Dec; 6(4):241-3. PubMed ID: 1667485
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic significance of antibodies to the Epstein-Barr virus-specific membrane antigen gp250.
    Jilg W; Wolf H
    J Infect Dis; 1985 Jul; 152(1):222-5. PubMed ID: 2989385
    [No Abstract]   [Full Text] [Related]  

  • 3. Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin.
    Ragot T; Finerty S; Watkins PE; Perricaudet M; Morgan AJ
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():501-7. PubMed ID: 8383183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved immunofluorescence antigens for detection of immunoglobulin M antibodies to Epstein-Barr viral capsid antigen and antibodies to Epstein-Barr virus nuclear antigen.
    Gallo D; Walen KH; Riggs JL
    J Clin Microbiol; 1982 Feb; 15(2):243-8. PubMed ID: 6279691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rheumatoid arthritis associated nuclear antigen (RANA) and Epstein-Barr virus (EBV)].
    Li ZG
    Zhonghua Yi Xue Za Zhi; 1988 Aug; 68(8):447-9, 32. PubMed ID: 2852534
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serological diagnosis of infectious mononucleosis caused by Epstein-Barr virus].
    de Ory F
    Enferm Infecc Microbiol Clin; 1991 Jan; 9(1):63-4. PubMed ID: 1851444
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced expression of the Epstein-Barr virus latent membrane protein by a recombinant vaccinia virus.
    Stewart JP; Hampson IN; Heinrich HW; Mackett M; Arrand JR
    J Gen Virol; 1989 May; 70 ( Pt 5)():1231-7. PubMed ID: 2543776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of nonhuman primates for antibodies reactive with Epstein-Barr virus (EBV) antigens and susceptibility of their lymphocytes for immortalization with EBV.
    Ishida T; Yamamoto K
    J Med Primatol; 1987; 16(6):359-71. PubMed ID: 2828628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis.
    Mueller N; Evans A; Harris NL; Comstock GW; Jellum E; Magnus K; Orentreich N; Polk BF; Vogelman J
    N Engl J Med; 1989 Mar; 320(11):689-95. PubMed ID: 2537928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epstein-Barr virus infection and immune responses in primary immunodeficiency syndromes].
    Sakiyama Y
    Hokkaido Igaku Zasshi; 1984 Jul; 59(4):379-82. PubMed ID: 6092247
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of immunity to Epstein-Barr virus in Malaysian children.
    Yadav MS; Malliga N; Ablashi DV
    Microbiologica; 1987 Jan; 10(1):29-35. PubMed ID: 3033449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.
    Epstein MA; Morgan AJ
    Clin Exp Immunol; 1983 Aug; 53(2):257-71. PubMed ID: 6309441
    [No Abstract]   [Full Text] [Related]  

  • 13. Contribution to rapid diagnosis of infectious mononucleosis.
    Franková V; Stanková M; Kouba K; Hásková V; Pavlík E
    Acta Virol; 1986 May; 30(3):234-42. PubMed ID: 2874728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults.
    Moutschen M; Léonard P; Sokal EM; Smets F; Haumont M; Mazzu P; Bollen A; Denamur F; Peeters P; Dubin G; Denis M
    Vaccine; 2007 Jun; 25(24):4697-705. PubMed ID: 17485150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vero cell-expressed Epstein-Barr virus (EBV) gp350/220 protects marmosets from EBV challenge.
    Emini EA; Schleif WA; Silberklang M; Lehman D; Ellis RW
    J Med Virol; 1989 Feb; 27(2):120-3. PubMed ID: 2537882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological markers for Epstein-Barr virus infection in chronic carriers of hepatitis B surface antigen who live in northern Canada.
    Minuk GY; Sekla LH; Nicolle LE
    J Infect Dis; 1987 Jul; 156(1):202-4. PubMed ID: 3036958
    [No Abstract]   [Full Text] [Related]  

  • 17. A prospective study of antibodies to Epstein-Barr virus DNase and viral capsid antigen for prognostication of patients with nasopharyngeal carcinoma.
    Hsu MM; Chen JY; Chen CJ
    Taiwan Yi Xue Hui Za Zhi; 1988 Oct; 87(10):984-8. PubMed ID: 2853721
    [No Abstract]   [Full Text] [Related]  

  • 18. [Purification and application of viral capsid antigen of Epstein-Barr virus].
    Zhou W; Gu S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):252-5. PubMed ID: 15617341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infectious mononucleosis].
    Wakiguchi H; Maeda A; Dohno S; Sato T
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():625-9. PubMed ID: 16615548
    [No Abstract]   [Full Text] [Related]  

  • 20. Hodgkin disease in children: clinicoepidemiologic and viral (Epstein-Barr virus) analyses.
    Cavdar AO; Pamir A; Gözdaşoglu S; Babacan E; Yavuz G; Unal E; Uluoglu O; Taçyildiz N; Ikincioğullari A
    Med Pediatr Oncol; 1999 Jan; 32(1):18-24. PubMed ID: 9917748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.